Larimar Therapeutics Inc. (LRMR)
Market Closed
3 Jun, 20:00
$
3. 2000
-0.1
-3.03%
$
301.23M Market Cap
- P/E Ratio
- Div Yield
1,851,306 Volume
-1.23 Eps
$ 3.3
Previous Close 
Want to track LRMR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
LRMR Earnings Reports FAQ
What is the earnings per share (EPS) for LRMR?
The current EPS is -1.23.
What is the company's earnings growth rate?
Larimar Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Larimar Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Larimar Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LRMR at this time, as Larimar Therapeutics Inc has no recent EPS data to calculate it.
